FTSE 100 (UKX) closes above 10,400 points on July 28, 2026
Pending
✦ AI-generated prediction
Published on 22. July 2026
·
Predicted for 28. July 2026
·
Based on: Statistical Pattern
The existing platform prediction has FTSE 100 above 10,300 on July 25, implying current index at ~10,250–10,350. Reaching 10,400 by July 28 requires ~+1.0% over three additional trading days. Positive drivers: BoE holds Bank Rate at 3.75% on July 30 (existing platform forecast), strong UK corporate earnings (Unilever, AstraZeneca). GBP/USD fell to 1.338 on July 21 (–0.38%), boosting export-heavy FTSE constituents. Headwinds: weaker UK consumer confidence.
Data basis for this prediction
- FTSE 100 Schluss ca. 10.300 (impliziert durch offene Plattform-Prognose >10.300 am 25. Juli)
- GBP/USD: 1.338 am 21. Juli 2026; Wochenhoch 1.355 am 15. Juli (MTFX Historical Data)
- Bank of England: Bank Rate 3,75 % – Halten erwartet am 30. Juli 2026 (Reuters, 22. Juli 2026)
- FTSE 100 Jahresend-Ziel >11.000 (bestehende Plattform-Prognose 31. Dezember 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
Shell reports Q2 2026 results on July 30. The adjusted CCS earnings consensus is estimated at approx. USD 5.5–6.0bn, based on the historical quarterly run-rate of ~USD 5.9bn (FY2024 total: ~USD 23.7bn). Key beat drivers: (1) WTI rose to USD 84.42 in July 2026 (+14% over the month) on the US naval blockade — but Q2 billing period is April–June, so average oil prices in Q2 were likely USD 78–82/bbl; (2) integrated gas/LNG benefits from TTF stability (~EUR 58–60/MWh); (3) downstream margins recovering from 2024 weakness. No Polymarket/Kalshi markets found; calibrated on historical beat pattern and oil price trajectory.
📈 Economy
✦ AI
TotalEnergies reports Q2 2026 results on July 23, 2026 (8:00 AM CET). MarketBeat consensus is USD 2.68/share. Bull case: (1) Brent averaged well above Q2 2025 (when EPS was USD 1.57, a miss), (2) improving downstream margins, (3) BofA flagged 'better-than-feared' Q2 (MarketScreener, July 2026), (4) Q1 2026 adj. net income USD 5.4bn / EPS USD 2.45 beat consensus by +17.8%. Bear case: weaker LNG trading margins. WTI at USD 84.42 (July 22) supported by US naval blockade of Iranian ports since July 14. No Polymarket/Kalshi markets found; estimate based on analyst consensus and historical beat pattern.
📈 Economy
✦ AI
AstraZeneca reports Q2 2026 results on July 27, 2026. Consensus from 35 analysts stands at USD 2.50/ADS (Defense World); some sources cite up to USD 2.60. Q1 2026 core EPS was USD 2.58 (consensus: USD 2.52, beat: +USD 0.06). AZN reconfirmed FY2026 guidance for low double-digit core EPS growth at CER — a strong forward signal. Growth drivers: Tagrisso, Enhertu, Lynparza, and emerging CVRM franchise. AZN has beaten consensus in 4 of the last 5 quarters. Headwind: minor consensus reduction by Erste Group Bank on July 22, 2026.